Growth is a hallmark of all great companies, but the laws of gravity eventually take hold.
Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Despite beating on the top and bottom lines, tariff uncertainty makes the outlook for ISRG stock fluid; investors may want to wait for clarity before jumping in
Intuitive Surgical's price target was cut to $590 on tariff concerns, but analysts remain positive on strong growth, new product cycle, and solid balance sheet.
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence.
Medical device company Merit Medical Systems (NASDAQ:MMSI)
will be announcing earnings results tomorrow after the bell. Here’s what investors should know.
Intuitive said it now expects full-year 2025 gross margins between 65% and 66.5%, with the tariff impact projected to grow each quarter through the end of the year.
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.
Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.2% year on year to $2.25 billion. Its non-GAAP profit of $1.81 per share was 4.4% above analysts’ consensus estimates.
